Viking Therapeutics Inc (VKTX)

NASDAQ HEALTHCARE
$30.89 +0.68% RSI 47 Neutral Add Alert

Moving Averages

SMA 200
$32.75
Price below

Company Profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$3.64B
P/E Ratio
None
EPS
$-4.15
Beta
0.71
Dividend Yield
0.00%
52-Week High
$43.15
52-Week Low
$22.96

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 45.0
VRTX
Vertex Pharmaceuticals Inc
RSI 48.0
CRSP
CRISPR Therapeutics AG
RSI 47.0
MRNA
Moderna Inc
RSI 43.0
SRPT
Sarepta Therapeutics Inc
RSI 33.0
EDIT
Editas Medicine Inc
RSI 47.0
IOVA
Iovance Biotherapeutics Inc
RSI 62.0
NVAX
Novavax Inc
RSI 54.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 53.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 42.0

Data last updated: May 12, 2026 at 6:16 AM EDT

Track VKTX for free

Get e-mail RSI alerts when Viking Therapeutics Inc enters oversold or overbought territory. Free forever.

Add Alert